Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency

CONTEXT: No consensus has been reached regarding the glucocorticoid (GC) to use for congenital adrenal hyperplasia (CAH) during adulthood. Dexamethasone (DEX), because of its longer half-life, could improve compliance; however, no data are available regarding the long-term effects of DEX therapy. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Seraphim, Carlos E, Frassei, Juliana S, Pessoa, Bruna S, Scalco, Renata C, Miranda, Mirela C, Madureira, Guiomar, Mendonca, Berenice B, Bachega, Tania A S S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676077/
https://www.ncbi.nlm.nih.gov/pubmed/31384718
http://dx.doi.org/10.1210/js.2019-00123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676077/
https://www.ncbi.nlm.nih.gov/pubmed/31384718
http://dx.doi.org/10.1210/js.2019-00123

Ejemplares similares